Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors.

Clinical trial NCT03335059 · TERMINATED

Trial details

NCT number: NCT03335059
Sponsor: Medical Enterprises Ltd.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Bladder Cancer Bladder Neoplasm Bladder Tumors Cancer of Bladder Cancer of the Bladder Malignant Tumor of Urinary Bladder Neoplasms, Bladder Urinary Bladder Cancer Carcinoma in Situ of Bladder Papillary Carcinoma of Bladder (Diagnosis)BCG-Unresponsive Bladder Cancer

Start date: 2019-04-04
Primary completion: 2020-02-26
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.